Radiation Oncology Journal

The Korean Society for Radiation Oncology (대한방사선종양학회)
권호 표지
DOI QR코드

DOI QR Code

Troglitazone and tumor inhibition: an evolving concept in the management of systemic malignancies

  • Received : 2012.12.02
  • Accepted : 2012.12.06
  • Published : 2012.12.30
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. An Z, Liu X, Song H, et al. Effect of troglitazone on radiation sensitivity in cervix cancer cells. Radiat Oncol J 2012;30:78- 87. https://doi.org/10.3857/roj.2012.30.2.78
  2. Wang C, Wang J, Bai P. Troglitazone induces apoptosis in gastric cancer cells through the NAG-1 pathway. Mol Med Report 2011;4:93-7.
  3. Ban JO, Kwak DH, Oh JH, et al. Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone. Chem Biol Interact 2010; 188:75-85. https://doi.org/10.1016/j.cbi.2010.06.001
  4. Roth W, Grund K, Wiestler OD, Schirmacher P. The antidiabetic drug troglitazone sensitizes colon cancer cells to TRAIL-induced apoptosis by down-regulating FLIP. Verh Dtsch Ges Pathol 2007;91:294-301.
  5. Qiao L, Dai Y, Gu Q, et al. Loss of XIAP sensitizes colon cancer cells to PPARgamma independent antitumor effects of troglitazone and 15-PGJ2. Cancer Lett 2008;268:260-71. https://doi.org/10.1016/j.canlet.2008.04.003
  6. Rashid-Kolvear F, Taboski MA, Nguyen J, Wang DY, Harrington LA, Done SJ. Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cells. BMC Cancer 2010;10:390. https://doi.org/10.1186/1471-2407-10-390
  7. Davies GF, Ross AR, Arnason TG, Juurlink BH, Harkness TA. Troglitazone inhibits histone deacetylase activity in breast cancer cells. Cancer Lett 2010;288:236-50. https://doi.org/10.1016/j.canlet.2009.07.011
  8. Yu HN, Lee YR, Noh EM, et al. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand. Cell Biol Int 2008;32:906-12. https://doi.org/10.1016/j.cellbi.2008.04.011
  9. Ban JO, Oh JH, Son SM, et al. Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of $NF{\kappa}B$ via suppression of GSK-$3{\beta}$ expression. Cancer Biol Ther 2011;12:288-96. https://doi.org/10.4161/cbt.12.4.15961
  10. Bolden A, Bernard L, Jones D, Akinyeke T, Stewart LV. The PPAR gamma agonist troglitazone regulates Erk 1/2 phosphorylation via a PPAR$\gamma$ -independent, MEK-dependent pathway in human prostate cancer cells. PPAR Res 2012;2012:929052.
  11. Akinyeke TO, Stewart LV. Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPAR$\gamma$ -independent mechanism. Cancer Biol Ther 2011;11:1046-58. https://doi.org/10.4161/cbt.11.12.15709